Bladder cancer is recognized as the most expensive malignancy per patient due to the necessity of persistent, invasive monitoring and biopsy to diagnose or rule out recurrence, the rate of which approaches 40% of cases. Urine analysis as a screening diagnostic... ...

请注册登录后继续浏览